A Phase Ib, open-label, multicentre study of oral LXH254 in combination with oral LTT462 in adult patients with advanced or metastatic KRAS or BRAF mutant Non-small Cell Lung Cancer.

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date16/09/19 → 31/12/24

Keywords

  • Medical Oncology
  • Lung cancer
  • Clinical trial